These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 413062)

  • 21. Waterborne Pseudomonas septicemia.
    Vanholder R; Vanhaecke E; Ringoir S
    ASAIO Trans; 1990; 36(3):M215-6. PubMed ID: 2123634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa bacteremia in a dialysis unit. 11. Relationship to reuse of coils.
    Wagnild JP; McDonald P; Craig WA; Johnson C; Hanley M; Uman SJ; Ramgopal V; Beirne GJ
    Am J Med; 1977 May; 62(5):672-6. PubMed ID: 404879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contamination of dialysis water and dialysate. A survey of 30 centers.
    Bambauer R; Schauer M; Jung WK; Daum V; Vienken J
    ASAIO J; 1994; 40(4):1012-6. PubMed ID: 7858320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients.
    Yamagami S; Adachi T; Sugimura T; Kishimoto T; Maekawa M; Niwa M; Shaldon S
    ASAIO Trans; 1989; 35(3):331-3. PubMed ID: 2597475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Machineless" nutritional hemodialysis.
    Roberts M; Barney MH; Trott MA; Montez AJ; Stephens VM; Lee DB
    ASAIO Trans; 1989; 35(3):270-3. PubMed ID: 2512967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
    Kiaii M; Djurdjev O; Farah M; Levin A; Jung B; MacRae J
    JAMA; 2011 Oct; 306(15):1679-87. PubMed ID: 22009100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrapure dialysate: facts and myths.
    Bommer J; Jaber BL
    Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis.
    Schindler R; Lonnemann G; Schäffer J; Shaldon S; Koch KM; Krautzig S
    Nephron; 1994; 68(2):229-33. PubMed ID: 7830861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adsorption of beta 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures.
    Goldman M; Lagmiche M; Dhaene M; Amraoui Z; Thayse C; Vanherweghem JL
    Int J Artif Organs; 1989 Jun; 12(6):373-8. PubMed ID: 2674020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testing.
    Krautzig S; Lonnemann G; Shaldon S; Koch KM
    Artif Organs; 1996 Jul; 20(7):798-800. PubMed ID: 8828771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial contamination of dialysate in dialysis-associated endotoxaemia.
    Watzke H; Mayer G; Schwarz HP; Stanek G; Rotter M; Hirschl AM; Graf H
    J Hosp Infect; 1989 Feb; 13(2):109-15. PubMed ID: 2567302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
    Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
    Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Net ultrafiltration may not eliminate backfiltration during hemodialysis with highly permeable membranes.
    Leypoldt JK; Schmidt B; Gurland HJ
    Artif Organs; 1991 Jun; 15(3):164-70. PubMed ID: 1907821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
    Masakane I
    Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of bacteremia and endotoxemia despite contaminated dialyzate.
    Bernick JJ; Port FK
    Clin Nephrol; 1980 Jul; 14(1):13-7. PubMed ID: 7408251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enigmatic fever during hemodialysis.
    Morris AJ; Bilinsky RT
    IMJ Ill Med J; 1973 Apr; 143(4):366-8. PubMed ID: 4144307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.